Stockscreener 앱 받기
0.975
10.78%
0.0949
시간 외 거래:
.89
-0.085
-8.72%
전일 마감가:
$0.8801
열려 있는:
$0.89
하루 거래량:
179.24K
Relative Volume:
0.17
시가총액:
$2.63M
수익:
$819.00K
순이익/손실:
$-17.70M
주가수익비율:
-0.077
EPS:
-12.6647
순현금흐름:
$-8.45M
1주 성능:
-20.08%
1개월 성능:
-20.73%
6개월 성능:
-63.07%
1년 성능:
-83.96%
1일 변동 폭
$0.8874
$1.0499
1주일 범위
$0.7906
$1.25
52주 변동 폭
$0.7906
$15.68
Catheter Precision Inc. Stock (VTAK) Company Profile
명칭
Catheter Precision Inc.
전화
973 691 2000
주소
1670 Highway 160 West, Suite 205, Fort Mill
Compare VTAK vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTAK
Catheter Precision Inc.
|
0.975 | 2.37M | 819.00K | -17.70M | -8.45M | -12.66 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-08-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2018-11-02 | 개시 | Maxim Group | Buy |
Catheter Precision Inc. 주식(VTAK)의 최신 뉴스
FLYTE EMERGES AS DIRECT BENEFICIARY AS RISING FUEL COSTS DRIVE AIRLINE RETREAT FROM SHORT-HAUL ROUTES - GlobeNewswire Inc.
VTAK Definitive Agreement to Acquire 100% of Fly Flyte Inc. Obtains Shareholder Approval - 富途牛牛
VTAK to acquire Fly Flyte - Medical Buyer
Catheter Precision (VTAK) Gains Shareholder Approval for Acquisi - GuruFocus
Catheter Precision (VTAK) Gains Approval for Acquisition of Fly Flyte - GuruFocus
Catheter Precision (VTAK) Completes Acquisition of Fly Flyte - GuruFocus
VTAK adds FAA-certified jet operator, bringing in revenue now - Stock Titan
Catheter Precision, Inc. 8-K Filing: Approval of Common Stock Issuance for Preferred Stock Conversion (April 15, 2026) - Minichart
Catheter Precision stockholders approve share issuances and reverse split By Investing.com - Investing.com Canada
Catheter Precision stockholders approve share issuances and reverse split - Investing.com
Catheter Precision (NYSE: VTAK) records 49.5% shareholder turnout - Stock Titan
Trading Recap: Will Catheter Precision Inc stock benefit from M A2026 Volume Leaders & Safe Entry Zone Tips - baoquankhu1.vn
Catheter Precision Inc Announces Accepted Publication Of VIVO Clinical Evidence In EP Europace - marketscreener.com
Catheter Precision Announces Accepted Publication in Leading European Medical Journal - The Manila Times
31-patient heart study backs Catheter Precision mapping tool - Stock Titan
Breakout Move: Will Catheter Precision Inc benefit from green energy policies2026 Technical Overview & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
VTAK Should I Buy - Intellectia AI
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Buybacks Report: Will Catheter Precision Inc benefit from green energy policies2026 Geopolitical Influence & High Return Trade Opportunity Guides - baoquankhu1.vn
FOMO Trade: Is Catheter Precision Inc part of any ETF2026 Rallies & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Catheter Precision to Attend the Annual European Heart Rhythm Association Conference - The Manila Times
First large Europe event since LockeT CE Mark sends Catheter Precision to Paris - Stock Titan
Aug Outlook: Is Catheter Precision Inc stock undervalued right nowEarnings Risk Summary & High Accuracy Trade Alerts - baoquankhu1.vn
Wall Street Recap: Can Catheter Precision Inc deliver consistent EPS growth2026 Bull vs Bear & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
New LockeT Data Accepted in Leading Electrophysiology Journal - The Manila Times
A 139-patient heart-closure study puts Catheter Precision in a top journal - Stock Titan
Catheter Precision seeks buyer for cardiac device business By Investing.com - Investing.com Australia
Catheter Precision (VTAK) Seeks Buyer for Cardiac Electrophysiol - GuruFocus
Catheter Precision Inc engaged a strategic advisor to formally market for sale its cardiac electrophysiology business - marketscreener.com
Catheter Precision Engages Strategic Advisor - The Manila Times
Catheter Precision seeks buyer for cardiac device business - Investing.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com
Catheter Precision puts heart device business up for sale, pivots to aviation - Stock Titan
Catheter Precision reports net loss of USD 17.2M in 2025 - Medical Buyer
VTAK PE Ratio & Valuation, Is VTAK Overvalued - Intellectia AI
Catheter Precision reports 95% revenue increase, acquires aviation firm - Investing.com
Catheter Precision (NYSE: VTAK) posts 2025 loss, revenue up 95% and buys Flyte aviation unit - Stock Titan
Catheter Precision 2025 10-K: Revenue $0.82M, Net Loss $17.7M - TradingView
Catheter Precision: 2025 revenue rose to $819K, but a $17.2M net loss and urgent capital needs raise going concern risks - TradingView — Track All Markets
Catheter Precision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Catheter Precision (NYSE: VTAK) flags going concern risk while expanding VIVO and LockeT - Stock Titan
Catheter Precision reports 95% revenue increase, acquires aviation firm By Investing.com - Investing.com Canada
Catheter Precision reports 2025 results and updates on strategic expansion - marketscreener.com
Catheter Precision Reports 2025 Results and Updates on Strategic Expansion - MarketScreener
Catheter Precision Reports 2025 Results And Updates On Strategic Expansion - TradingView
Catheter Precision (VTAK) CEO awarded 40,000 options at $1.15 exercise price - Stock Titan
Catheter Precision (VTAK) CFO awarded options for 40,000 shares at $1.15 - Stock Titan
Catheter Precision (VTAK) director receives 40,000 stock options at $1.15 strike - Stock Titan
Director James Caruso receives 40,000 VTAK options at $1.15 exercise price - Stock Titan
[Form 4] Catheter Precision, Inc. Insider Trading Activity - Stock Titan
Chart Watch: Can Catheter Precision Inc continue delivering strong returnsPortfolio Risk Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Catheter Precision Inc. (VTAK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.72%
자본화:
|
볼륨(24시간):